Explore how KIFFIK is transforming diagnostics with a scalable ISF platform and strong market opportunity.
Why invest in KIFFIK?
550B+ Addressable Market
Diagnostics is one of the fastest growing sectors with high demand for convenient, non-invasive testing.
First-Mover Advantage
No one else is delivering aptamer-based, ISF-driven diagnostics at scale.
Platform Scalability
Oncology is just the beginning — our technology addresses cardiometabolic, infectious, and wellness markets.
The KIFFIK Platform Opportunity
KIFFIK’s platform is positioned to capture a meaningful share of the rapidly expanding diagnostics market and beyond, with a total addressable market (TAM) projected to reach approximately $1.8 trillion by 2035. With nearly $550 billion accessible today and annual growth rates of 8–10%, KIFFIK is uniquely placed to drive innovation across healthcare verticals including oncology, cardiometabolic, infectious disease, and neurological applications.
TAM 2035: ≈ $
0
Trillion
Accessible Today: ≈ $
0
Billion
Annual Growth Rate: 8-
0
% CAGR
|
Vertical
|
2025 TAM
|
CAGR
|
2035 TAM
|
KIFFIK Role
|
|---|---|---|---|---|
|
Oncology Diagnosis & Monitoring
|
$150B
|
8.2%
|
$325B
|
Tumor ISF biomarkers, MRD tracking
|
|
Cardiovascular Diagnostics
|
$85B
|
7.5%
|
$175B
|
ISF troponins, BMP
|
|
Autoimmune Monitoring
|
$60B
|
7.1%
|
$120B
|
Cytokine storm detection
|
|
Infectious Disease
|
$35B
|
5.8%
|
$62B
|
ISF viral load tracking
|
|
Neurological
|
$45B
|
8.5%
|
$105B
|
Alzheimer's, concussion monitoring
|
|
Metabolic Disorders
|
$100B
|
9.1%
|
$235B
|
ISF lipids, insulin, ApoB
|
|
Clinical Trials (Drug Development)
|
$70B
|
7.9%
|
$150B
|
Biomarker endpoints, real-time feedback
|
|
Companion Diagnostics
|
$80B
|
9.3%
|
$195B
|
Drug-diagnostic pairs
|
|
Remote/Home Health
|
$120B
|
10.5%
|
$310B
|
ISF Wearables
|
|
Veterinary Diagnostics
|
$25B
|
6.2%
|
$45B
|
Pet/livestock ISF monitoring
|
|
Military & Defense
|
$15B
|
5.0%
|
$24B
|
ISF for TBI, chemical exposure
|
|
Consumer Wellness
|
$85B
|
11.2%
|
$250B
|
Personalized health, anti-aging
|
Embedded Sources
Led by experts, built for scale
Our leadership team brings deep experience in diagnostics, commercial growth, and medtech innovation — supported by a world-class advisory board.
Access our investor materials.
Download our one-pager to learn more about the KIFFIK opportunity.
Let's start a conversation
We’re actively engaging strategic investors, M&A partners, and early collaborators.
